| フルテキストURL | |
| 著者 |
Ueno, Hiroshi
Department of Medical Technology, Kawasaki University of Medical Welfare
Kitano, Eriko
Department of Psychiatry, Kawasaki Medical School
Mori, Sachiko
Department of Psychiatry, Kawasaki Medical School
Takahashi, Yu
Department of Psychiatry, Kawasaki Medical School
Murakami, Shinji
Department of Psychiatry, Kawasaki Medical School
Wani, Kenta
Department of Psychiatry, Kawasaki Medical School
Matsumoto, Yosuke
Department of Neuropsychiatry, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
publons
researchmap
Okamoto, Motoi
Department of Medical Technology, Graduate School of Health Sciences, Okayama University
Kaken ID
publons
researchmap
Ishihara, Takeshi
Department of Psychiatry, Kawasaki Medical School
|
| 抄録 | Chronic fluoxetine administration has been reported to enhance neural plasticity in the adult brain, but the underlying structural correlates remain incompletely understood. In particular, the impact of fluoxetine on aggrecan-positive perineuronal nets (PNNs)—critical regulators of plasticity—is largely unknown. We investigated whether chronic fluoxetine treatment (20 mg/kg/day, i.p., 21 days) alters behavior and PNN expression in adult male C57BL/6 N mice. Behavioral assessments included grip strength, hot plate, light/dark transition, elevated plus-maze, open field, Y-maze, social interaction, tail suspension, Porsolt forced swim, and passive avoidance tests. To evaluate structural plasticity, we performed immunohistochemical analyses of parvalbumin (PV)-positive neurons and PNNs using aggrecan-specific antibodies (Cat-315, AB1031) in the primary somatosensory cortex and hippocampus. Fluoxetine-treated mice exhibited increased exploration and reduced anxiety-like behavior in light/dark transition and elevated plus-maze tests, with no significant changes in grip strength or nociception. They also showed increased locomotor activity (distance and entries) in the Y-maze, but did not significantly alter spontaneous alternation performance, and increased social interaction, the latter possibly reflecting abnormal social behavior. No significant differences were observed in depression-like behavior as assessed by tail suspension and forced swim tests. Passive avoidance performance was impaired, suggesting a decline in cognitive function. Immunohistochemical analysis revealed a significant reduction in aggrecan-positive PNN density, particularly in layer 4 of the primary somatosensory cortex and in the CA1 and CA3 regions of the hippocampus. Our results indicate that chronic fluoxetine administration induces behavioral and structural changes indicative of reactivated neuroplasticity. Importantly, these changes are associated with a region- and layer-specific reduction of aggrecan-positive PNNs, underscoring their critical role in modulating adult cortical plasticity.
|
| キーワード | Fluoxetine
Neuroplasticity
Perineuronal nets
Aggrecan
Parvalbumin
Behavior
|
| 発行日 | 2025-12
|
| 出版物タイトル |
IBRO Neuroscience Reports
|
| 巻 | 19巻
|
| 出版者 | Elsevier BV
|
| 開始ページ | 781
|
| 終了ページ | 791
|
| ISSN | 2667-2421
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| OAI-PMH Set |
岡山大学
|
| 著作権者 | © 2025 The Author(s).
|
| 論文のバージョン | publisher
|
| DOI | |
| Web of Science KeyUT | |
| 関連URL | isVersionOf https://doi.org/10.1016/j.ibneur.2025.10.012
|
| ライセンス | http://creativecommons.org/licenses/by-nc-nd/4.0/
|
| 助成情報 |
22K11330:
細胞外マトリックス分子に着目した神経可塑性制御による神経発達障害の治療薬の開発
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
|